The distribution of selectively administered papaverine was determined in nine patients with delayed cerebral vasospasm in the territories of the anterior (ACA) and/or middle cerebral arteries (MCA) sec ondary to aneurysmal subarachnoid hemorrhage by simultaneous infusion with technetium-99m-hex amethyl-propyleneamine oxime (<SUP>99m</SUP>Tc-HMPAO). Four of the nine patients had a ruptured anterior com municating artery aneurysm, four had an internal carotid artery aneurysm, and the remaining one had a MCA aneurysm. Trapping of anterior communicating artery was carried out in one case and clipping of aneurysms in other eight cases. Neurological deterioration with hemiparesis, paraparesis, and/or somnolence appeared between postsurgical Days 8 and 13 due to delayed cerebral vasospasm in all patients. Intraarterial infusion of 40 mg of papaverine containing 37 MBq of <SUP>99m</SUP>Tc-HMPAO was per formed from the C<SUB>1</SUB> segment in seven of the nine patients and from the C<SUB>4</SUB> segment in the other two patients. <SUP>99m</SUP>Tc-HMPAO was distributed in the territories of the ACA and MCA in the two patients who were treated with intraarterial infusion of papaverine from the C<SUB>4</SUB> segment, but was distributed only to the territory of the ACA in four patients who were treated with intraarterial infusion of papaverine from the C<SUB>1</SUB> segment at 1 ml/min. In contrast, <SUP>99m</SUP>Tc-HMPAO was distributed in the territories of the ACA and MCA in the three patients who were treated with papaverine from the C<SUB>1</SUB> segment at 2 ml/min, although most <SUP>99m</SUP>Tc-HMPAO was distributed in the territory of the ACA. Vasospasm of the ACA can be treated by intraarterial infusion of papaverine from the C<SUB>1</SUB> segment at 1 ml/min when selective catheteri zation to the ACA is difficult to perform.
Introduction
The treatment of cerebral vasospasm has improved greatly with the use of percutaneous transluminal an gioplasty (PTA) and/or superselective infusion of papaverine.5,8,1°,12,1') The first treatment of cerebral vasospasm after subarachnoid hemorrhage (SAH) with transluminal balloon angioplasty was reported in 1984.17) Subsequent applications of this technique have generally achieved favorable results in patients with symptomatic vasospasm refractory to conven tional therapy. 1,12) However, the balloon catheter cur rently available for PTA is limited for reaching distal ly affected vessels or vessels with short and sharply angled origins, such as the distal segments of the middle cerebral artery (MCA) and the Al segment of the anterior cerebral artery (ACA). Moreover, super selective catheterization of the ACA using the Track er-18 or Tracker-10 is sometimes difficult to per form. ') Papaverine is only effective on vessels when de livered by blood flow. Papaverine will be relatively ineffective, for example, in cases of ACA spasm with a normal MCA, since the blood flow preferen tially delivers papaverine infused into the internal carotid artery (ICA) to the MCA. However, this prob lem can be circumvented by transiently occluding the MCA with a balloon and infusing papaverine in the more proximal portion of the ICA.10) Super selective catheterization of the Al segment just proximal to a spastic portion of A1, followed by selective infusion of papaverine, achieved dilation of the Al segment.') Superselective catheterization of the M1 segment of the MCA is thought to be rel atively easy, whereas catheterization of the Al seg ment is sometimes difficult and the guidewire may injure the arterial wall or perforate the spastic ves sel.
This study determined the distribution of papav erine infused from the C1 segment of the ICA simultaneously with technetium-99m-hexamethyl propyleneamine oxime (99mTc-HMPAO) as a tracer.') Clinical Materials and Methods
I. Clinical materials
This study included nine patients with vasospasm of the ICA or MCA treated between August 1993 and January 1995. Four patients had a ruptured anterior communicating artery (AcomA) aneurysm, four had a ruptured ICA-posterior communicating artery aneurysm, and the other had a ruptured MCA aneurysm. Seven patients were classified in clinical grade II, and two in clinical grade III.') Computed tomography (CT) performed on admission in all patients demonstrated group 3 SAW) Surgery was performed on the day of admission following completion of diagnostic angiography.15) Trapping of the AcomA aneurysm was performed in Case 2, and aneurysmal neck clipping in the other eight cases. All patients had clear consciousness and no neurological deficit the day after the operation. Delayed ischemic neurological deficits appeared in all patients (Table 1) .
II. Treatment and distribution study
A Tracker-10 microcatheter and guidewire system (Target Therapeutics, Inc., Fremont, Cal., U.S.A.) was advanced coaxially to the C1 or C4 segment through a 5 French angiographic catheter. In seven (Cases 1-7) of the nine patients, 99mTc-HMPAO and papaverine diluted with normal saline was infused through the microcatheter located in the C, segment. In the remaining two patients (Cases 8 and 9), papaverine was infused through the microcatheter in the C4 segment (Table 1) .
Selective infusion was performed using a trans femoral approach under local anesthesia with full heparinization. The patient's neurological condition was carefully monitored throughout the procedure. After completion of papaverine infusion, selective angiograms of the ICA were obtained through the guiding catheter. A 99mTc-HMPAO single photon emission computed tomography (SPECT) study was performed after the angiography. The distribution of 99mTc -HMPAO was determined and compared with perfusion maps obtained before (Cases 2, 5, 6, and 7) or just after (Cases 1, 3, 4, 8, and 9) the appearance of symptomatic vasospasm.
III.
Control studies
The control group consisted of four patients in whom cerebral angiography showed neither steno sis nor occlusion in the territories of the ACAs or MCAs. The four patients underwent subtotal resec tion of glioblastoma multiforme followed by conven tional radiation therapy, and were treated with 1-(4 amino methylpyridine-5-yl)-methyl-3-(2-chloroethyl) 3-nitrosourea hydrochloride (ACNU) infused from the C1 segment between July 1993 and January 1994.9'16) A total of 37 MBq of 99mTc-HMPAO and 50 mg of ACNU were mixed and diluted with 20 ml of normal saline and infused at 1 ml/min through a Tracker-10 located in the C1 segment (Table 2) .
Results

I. Angiographic and clinical results
The spastic ACAs became dilated just after termi nation of infusion of papaverine in Cases 2-4 and all three manifested improvement of level of parapare sis and/or consciousness. The spastic ACA and MCA became dilated just after termination of infu sion of papaverine in Cases 8 and 9, and both manifested improvement of hemiparesis and/or lev el of consciousness. Vasospasm in the territory of the right MCA showed no improvement after com pletion of infusion of papaverine from the right C1 segment in Case 1, but improved just after comple tion of infusion of papaverine from the right M1 seg ment. Vasospasm in the territory of the MCA showed slight improvement after completion of infu sion of papaverine from the C, segment in Cases 5 7. Eight patients were discharged without neurologi cal deficit (Glasgow Outcome Scale 7)) 34 to 42 days af ter the onset of SAH. The other patient (Case 5) was discharged with right hemiparesis 55 days after the onset of SAH (Table 1) .
II. Distribution of 99mTc-HMPAO
99mTc -HMPAO was homogeneously distributed to the territories of the ACA and MCA in Cases 8 and 9. 99mTc -HMPAO was confined to the territory of the left ACA in Case 2, and to the territories of the bilateral ACAs in Cases 3 and 4. 99mTc-HMPAO was also confined to the territory of the right ACA in Case 1. The territory of the MCA was not perfused with 99mTc-HMPAO in the four patients who received infusion of papaverine at 1 ml/min in the C1 segment (Cases 1-4). 99mTc-HMPAO was distributed to the territories of the ACA and MCA in Cases 5-7. However, most of the 99mTc-HMPAO was distributed to the territory of the ACA ( Table 1) . 99mTc -HMPAO was confined to the territory of the ACA in the four control patients (Table 2) . artery aneurysm (left), on Day 13 demonstrating severe and diffuse vasospasm in the territory of the left anterior cerebral artery (ACA) (center), and just after intraarterial infusion of papaverine demonstrating dilation of the left ACA (right).
Illustrative Cases
Case 2: A 48-year-old male was admitted with SAH due to rupture of an AcomA aneurysm (Fig. 1 left) . He was grade II clinically with group 3 CT findings. Trapping of the aneurysm was performed on the day of admission (Day 0). He had clear consciousness without neurological deficit the day after operation. 99mTc -HMPAO SPECT was performed on Day 10 when he became slightly somnolent, showing an in homogeneous region of low perfusion bilaterally ( Fig. 2 upper row) . On Day 13, he became paraparetic and somnolent. Cerebral angiography disclosed se vere vasospasm in the bilateral ACAs and develop ment of collaterals bilaterally via the posterior pericallosal arteries, and from the MCAs (Fig. 1 cen  ter) . A Tracker-10 was introduced into the C1 seg ment just distal to the origin of the anterior choroidal artery of the right ICA through a 5 French angiographic catheter, and 40 mg of papaverine was infused, resulting in dilation of the right spastic ACA. The Tracker-10 was then introduced into the C1 segment of the left ICA (Fig. 3) , and 40 mg of papaverine and 37 MBq of 99mTc-HMPAO were in fused at 1 ml/min, resulting in dilation of the spastic left ACA (Fig. 1 right) . Just after termination of inter ventional treatment, 99mTc-HMPAO SPECT was per formed to obtain a 99mTc-HMPAO distribution map. 99mTc-HMPAO was present only in the territory of the left ACA (Fig. 2 lower row) . His neurological deficit completely disappeared on Day 14, and he was discharged on Day 34 without neurological deficit. Case 9: A 61-year-old male was admitted with SAH due to rupture of a right ICA-posterior communicat ing artery aneurysm. He was grade III clinically and had group 3 CT findings. Neck clipping of the aneurysm was performed on the day of admission, and his consciousness was clear without neurologi cal deficits the day after operation. ' Left hemiparesis and somnolence developed on Day 8. 99mTc-HMPAO SPECT performed on the same day demonstrated bilateral inhomogeneous regions of low perfusion and slightly lower perfu sion in the territory of the right MCA than in that of the left MCA (Fig. 4 upper row) . Cerebral an giography disclosed vasospasm in the right ACA and ipsilateral MCA. A Tracker-10 was advanced to the right C4 segment through a 5 French angiograph ic catheter (Fig. 5) , and 80 mg of papaverine and 37
MBq of 99mTc-HMPAO were infused resulting in dila tion of the spastic vessels. Just after termination of interventional treatment, 99mTc-HMPAO SPECT was performed to obtain a distribution map. 99mTc HMPAO was present in the territories of the right ACA and MCA (Fig. 4 lower row) . The left hemipare sis disappeared on Day 9 and his consciousness became clear on Day 10. He was discharged on Day 40 without neurological deficit. Case 6: A 55-year-old male was admitted with SAH due to a ruptured AcomA aneurysm. He was grade II clinically and had group 3 CT findings. Neck clip ping of the aneurysm was performed on the day of admission, and he manifested clear consciousness without neurological deficits the day after opera tion. 99mTc -HMPAO SPECT was performed on Day 7 when he showed slight somnolence. Cerebral perfu sion in the left cerebral hemisphere was slightly low er than that in the right hemisphere (Fig. 6 upper  row) . On Day 9, he showed right hemiparesis and somnolence. Cerebral angiography disclosed vasospasm in the left ACA and ipsilateral MCA. A Tracker-10 was introduced into the C1 segment just distal to the origin of the anterior choroidal artery of the left ICA through a 5 French angiographic catheter (Fig. 7) , and 40 mg of papaverine and 37 MBq of 99mTc-HMPAO in 40 ml of normal saline were infused at 2 ml/min, resulting in partial dila tion of the left ACA and MCA. Just after termination of interventional treatment, 99mTc-HMPAO SPECT was performed to obtain a distribution map. 99mTc HMPAO was present in the territories of the left ACA and the ipsilateral MCA. However, most 99mTc HMPAO was distributed in the territory of the left ACA (Fig. 6 lower row) . His neurological deficit com pletely disappeared on Day 14, and he was dis charged on Day 40 without neurological deficit. Case 10: A 66-year-old female had undergone sub total removal of glioblastoma multiforme located in the right frontal lobe on May 18, 1993, followed by conventional radiation therapy with a total dose of 50 Gy. She had left hemiparesis (4/5) after the treat ment. On July 17, 1993, a Tracker-10 was advanced to the right C1 segment. A total of 37 MBq of 99mTc HMPAO and 50 mg of ACNU in 20 ml of normal sa line was infused at 1 ml/min through the Tracker-10.
99mTc -HMPAO was present only in the territory of the right ACA (Fig. 8) . livered to the C1 segment was always attached to the medial inner lumen of the ICA. Therefore, if contrast medium or papaverine is injected as a bolus or at 2 ml/min, it is distributed to both the ACA and MCA. If papaverine is continuously in fused at a low flow rate (1 ml/min), it runs along the medial inner lumen of the ICA (laminar flow ef fect) 2,11,13,14) and enters only the ACA. When treatment of vasospasm in the territory of the ACA is necessary and selective catheterization to the ACA is difficult to perform, infusion of papaverine at 1 ml/min in the C1 segment will deliver the agent selectively to the ACA. 
